These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18594288)

  • 1. Clinically significant carbapenemases: an update.
    Walsh TR
    Curr Opin Infect Dis; 2008 Aug; 21(4):367-71. PubMed ID: 18594288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae.
    Swayne RL; Ludlam HA; Shet VG; Woodford N; Curran MD
    Int J Antimicrob Agents; 2011 Jul; 38(1):35-8. PubMed ID: 21549572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Livermore DM; Woodford N
    Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of carbapenemases on antimicrobial development and therapy.
    Livermore DM
    Curr Opin Investig Drugs; 2002 Feb; 3(2):218-24. PubMed ID: 12020049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.
    Gupta V
    Expert Opin Investig Drugs; 2008 Feb; 17(2):131-43. PubMed ID: 18230049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gram-negative bacteriae with resistance to carbapenems].
    Nordmann P
    Med Sci (Paris); 2010 Nov; 26(11):950-9. PubMed ID: 21106177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
    Landman D; Babu E; Shah N; Kelly P; Olawole O; Bäcker M; Bratu S; Quale J
    J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.
    Zhao WH; Hu ZQ
    Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182.
    Kim CK; Lee Y; Lee H; Woo GJ; Song W; Kim MN; Lee WG; Jeong SH; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):432-8. PubMed ID: 20884158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
    Bedenić B
    Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic support of extended-spectrum beta-lactamases.
    Poirel L; Naas T; Nordmann P
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():75-81. PubMed ID: 18154530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenemases: molecular diversity and clinical consequences.
    Poirel L; Pitout JD; Nordmann P
    Future Microbiol; 2007 Oct; 2(5):501-12. PubMed ID: 17927473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.
    Shahid M; Sobia F; Singh A; Malik A; Khan HM; Jonas D; Hawkey PM
    Crit Rev Microbiol; 2009; 35(2):81-108. PubMed ID: 19514910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.
    Tsakris A; Poulou A; Pournaras S; Voulgari E; Vrioni G; Themeli-Digalaki K; Petropoulou D; Sofianou D
    J Antimicrob Chemother; 2010 Aug; 65(8):1664-71. PubMed ID: 20542902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carbapenemases in Pseudomonas spp].
    Juan Nicolau C; Oliver A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28 Suppl 1():19-28. PubMed ID: 20172419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
    Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
    J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of carbapenemase genes by multiplex real-time PCR.
    Monteiro J; Widen RH; Pignatari AC; Kubasek C; Silbert S
    J Antimicrob Chemother; 2012 Apr; 67(4):906-9. PubMed ID: 22232516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
    Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
    J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and screening of carbapenemase-producing Enterobacteriaceae.
    Nordmann P; Gniadkowski M; Giske CG; Poirel L; Woodford N; Miriagou V;
    Clin Microbiol Infect; 2012 May; 18(5):432-8. PubMed ID: 22507110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.